Free Trial

Biora Therapeutics Q4 2022 Earnings Report

Biora Therapeutics logo
$0.56 -0.06 (-9.89%)
(As of 12/20/2024 04:34 PM ET)

Biora Therapeutics EPS Results

Actual EPS
-$16.10
Consensus EPS
-$8.90
Beat/Miss
Missed by -$7.20
One Year Ago EPS
N/A

Biora Therapeutics Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
$0.11 million
Beat/Miss
Missed by -$100.00 thousand
YoY Revenue Growth
N/A

Biora Therapeutics Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

Biora Therapeutics Earnings Headlines

Biora Therapeutics Faces Nasdaq Delisting Challenges
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!
Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.
Biora Therapeutics Reports Q3 2024 Results and Updates
See More Biora Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biora Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biora Therapeutics and other key companies, straight to your email.

About Biora Therapeutics

Biora Therapeutics (NASDAQ:BIOR), a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

View Biora Therapeutics Profile

More Earnings Resources from MarketBeat

Upcoming Earnings